Literature DB >> 27811187

BCR inhibitor failure in CLL: an unmet need.

Nitin Jain1, Susan O'Brien2.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27811187     DOI: 10.1182/blood-2016-09-739664

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL.

Authors:  Kallesh D Jayappa; Craig A Portell; Vicki L Gordon; Brian J Capaldo; Stefan Bekiranov; Mark J Axelrod; L Kyle Brett; Julia D Wulfkuhle; Rosa I Gallagher; Emanuel F Petricoin; Timothy P Bender; Michael E Williams; Michael J Weber
Journal:  Blood Adv       Date:  2017-06-13

Review 2.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

3.  TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target.

Authors:  Emma Kennedy; Eve Coulter; Emma Halliwell; Nuria Profitos-Peleja; Elisabeth Walsby; Barnaby Clark; Elizabeth H Phillips; Thomas A Burley; Simon Mitchell; Stephen Devereux; Christopher D Fegan; Christopher I Jones; Rosalynd Johnston; Tim Chevassut; Ralph Schulz; Martina Seiffert; Angelo Agathanggelou; Ceri Oldreive; Nicholas Davies; Tatjana Stankovic; Triantafillos Liloglou; Chris Pepper; Andrea G S Pepper
Journal:  Blood       Date:  2021-06-03       Impact factor: 22.113

4.  The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia.

Authors:  Maria I Edilova; Jaclyn C Law; Safoura Zangiabadi; Kenneth Ting; Achire N Mbanwi; Andrea Arruda; David Uehling; Methvin Isaac; Michael Prakesch; Rima Al-Awar; Mark D Minden; Ali A Abdul-Sater; Tania H Watts
Journal:  Oncoimmunology       Date:  2021-09-23       Impact factor: 8.110

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.